Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,048 | 226 | 97.9% |
| Education | $88.74 | 2 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,107 | 55 | $0 (2024) |
| GlaxoSmithKline, LLC. | $863.25 | 47 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $262.83 | 14 | $0 (2024) |
| GENZYME CORPORATION | $258.59 | 19 | $0 (2024) |
| Grifols USA, LLC | $194.09 | 9 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $184.95 | 12 | $0 (2024) |
| Mylan Specialty L.P. | $182.68 | 12 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $160.81 | 9 | $0 (2024) |
| ABBVIE INC. | $152.28 | 6 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $106.43 | 12 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,829 | 99 | AstraZeneca Pharmaceuticals LP ($514.63) |
| 2023 | $1,660 | 86 | AstraZeneca Pharmaceuticals LP ($519.29) |
| 2022 | $218.99 | 11 | ABBVIE INC. ($45.16) |
| 2021 | $157.42 | 8 | AbbVie Inc. ($42.43) |
| 2020 | $39.17 | 3 | GlaxoSmithKline, LLC. ($27.47) |
| 2019 | $174.66 | 15 | Sunovion Pharmaceuticals Inc. ($73.95) |
| 2018 | $45.73 | 5 | Sunovion Pharmaceuticals Inc. ($32.48) |
| 2017 | $12.29 | 1 | GlaxoSmithKline, LLC. ($12.29) |
All Payment Transactions
228 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $7.59 | General |
| Category: Immunology | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.96 | General |
| 12/05/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/04/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Immunology | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $35.98 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $29.02 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.72 | General |
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.06 | General |
| 10/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $6.94 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $0.46 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/21/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $29.32 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 456 | 620 | $142,004 | $53,236 |
| 2022 | 4 | 150 | 228 | $27,273 | $15,610 |
| 2021 | 6 | 207 | 286 | $34,919 | $21,188 |
| 2020 | 6 | 197 | 301 | $42,703 | $20,960 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 53 | 126 | $58,086 | $18,968 | 32.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 70 | 125 | $35,020 | $11,198 | 32.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 61 | $11,223 | $5,378 | 47.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 40 | 53 | $5,777 | $3,156 | 54.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 45 | 51 | $6,229 | $2,853 | 45.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $5,478 | $2,635 | 48.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 18 | 18 | $5,526 | $2,336 | 42.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 19 | 19 | $3,116 | $1,603 | 51.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 16 | $3,328 | $1,444 | 43.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 23 | 28 | $1,652 | $1,054 | 63.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 12 | 12 | $1,956 | $1,046 | 53.5% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 16 | 16 | $2,464 | $1,004 | 40.7% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 25 | 25 | $725.00 | $222.06 | 30.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 23 | 23 | $874.00 | $176.18 | 20.2% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 25 | 25 | $550.00 | $164.03 | 29.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 94 | 152 | $14,440 | $9,147 | 63.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 29 | 29 | $6,293 | $3,408 | 54.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 14 | 32 | $5,685 | $2,501 | 44.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 15 | $855.00 | $553.13 | 64.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 99 | 167 | $15,865 | $10,955 | 69.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 51 | 51 | $11,067 | $6,107 | 55.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 14 | 25 | $4,125 | $1,908 | 46.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 19 | 19 | $2,698 | $1,311 | 48.6% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 12 | 12 | $840.00 | $717.86 | 85.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 12 | 12 | $324.00 | $189.96 | 58.6% |
About Dr. Anas Alsadi, MD
Dr. Anas Alsadi, MD is a Critical Care Medicine healthcare provider based in Anderson, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2008. The National Provider Identifier (NPI) number assigned to this provider is 1881841013.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anas Alsadi, MD has received a total of $4,137 in payments from pharmaceutical and medical device companies, with $1,829 received in 2024. These payments were reported across 228 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($4,048).
As a Medicare-enrolled provider, Alsadi has provided services to 1,010 Medicare beneficiaries, totaling 1,435 services with total Medicare billing of $110,993. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease, Pulmonary Disease
- Location Anderson, IN
- Active Since 08/19/2008
- Last Updated 02/06/2024
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1881841013
Products in Payments
- DUPIXENT (Biological) $606.41
- NUCALA (Biological) $483.23
- TRELEGY ELLIPTA (Drug) $345.22
- FASENRA (Biological) $317.77
- TEZSPIRE (Biological) $264.55
- Prolastin-C Liquid (Biological) $194.09
- GLASSIA (Biological) $184.95
- BREZTRI (Drug) $144.13
- YUPELRI (Drug) $126.14
- TYVASO (Drug) $89.79
- DIFICID (Drug) $78.99
- AIRSUPRA (Drug) $74.92
- LONHALA MAGNAIR (Drug) $73.95
- Arikayce (Drug) $71.26
- TEFLARO (Drug) $64.69
- OFEV (Drug) $62.20
- SYMBICORT (Drug) $59.05
- STIOLTO RESPIMAT (Drug) $57.95
- Yupelri (Drug) $56.54
- (8874) inCourage (Device) $48.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Anderson
David Mares, Md, MD
Critical Care Medicine — Payments: $1.4M
Pablo Molina, Md, MD
Critical Care Medicine — Payments: $14,829
Stephen Hand, Md, MD
Critical Care Medicine — Payments: $7,712
Moayyed Moallem, Md, MD
Critical Care Medicine — Payments: $4,275
Thomas Bright, Md, MD
Critical Care Medicine — Payments: $3,291
Christine Del Prado-Rico, Md, MD
Critical Care Medicine — Payments: $150.25